CNBC October 2, 2024
Key Points
– Eli Lilly will invest $4.5 billion to construct the Lilly Medicine Foundry, a center aimed at finding better ways to make medicines.
– The investment seeks to build upon Lilly’s success from Mounjaro and Zepbound, which are riding a wave of popularity in so-called GLP-1 drugs.
– Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, Chief Executive Officer David Ricks told CNBC.
Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines.
The facility, called the Lilly Medicine Foundry, will house development of new manufacturing methods with an eye toward efficiency. It’s a...
Today's Sponsors
Today's Sponsor